OUP Management Co., LLC
data from 30/09/2023
Capitalization
$ 44.466 M
-24.16 %
Performance
$ -122.112 M
-62.07 %
| Date | Ticket | Name | Weight | Capitalization | Share number | First added | Performance ($) | Performance (%) |
|---|---|---|---|---|---|---|---|---|
| 2023/09/30 | CNTA | Centessa Pharmaceuticals plc | 42.74% | 19.006 M $ | 2937615 | 2021/12/31 | 822.532 K $ | 4.52 % |
| 2023/09/30 | AVTE | Aerovate Therapeutics Inc. | 18.43% | 8.193 M $ | 603762 | 2021/12/31 | -2.161 M $ | -20.87 % |
| 2023/09/30 | Cyteir Therapeutics, Inc. | 15.71% | 6.985 M $ | 2459572 | 2021/12/31 | 590.297 K $ | 9.23 % | |
| 2023/09/30 | PMVP | PMV Pharmaceuticals, Inc. | 13.66% | 6.074 M $ | 989232 | 2021/12/31 | -118.707 K $ | -1.92 % |
| 2023/09/30 | GRPH | Graphite Bio | 2.27% | 1.008 M $ | 406308 | 2021/12/31 | -48.756 K $ | -4.62 % |
| 2023/09/30 | SELB | Selecta Biosciences, Inc. | 2.06% | 914.296 K $ | 862543 | 2021/12/31 | -51.752 K $ | -5.36 % |
| 2023/09/30 | VOR | Vor Biopharma Inc. | 1.79% | 794.394 K $ | 374714 | 2021/12/31 | -363.472 K $ | -31.39 % |
| 2023/09/30 | EFTR | eFFECTOR Therapeutics, Inc. | 1.38% | 615.316 K $ | 1025697 | 2021/12/31 | -236.320 K $ | -27.75 % |
| 2023/09/30 | DTIL | Precision BioSciences, Inc. | 0.86% | 383.592 K $ | 1123913 | 2021/12/31 | -207.923 K $ | -35.17 % |
| 2023/09/30 | SPRO | Spero Therapeutics, Inc. | 0.68% | 301.375 K $ | 249070 | 2021/12/31 | -59.776 K $ | -16.55 % |
| 2023/09/30 | IKNA | Ikena Oncology, Inc. | 0.26% | 116.187 K $ | 26833 | 2023/09/30 | 0.000 $ | 0.00 % |
| 2023/09/30 | FIXX | Homology Medicines, Inc. | 0.17% | 74.880 K $ | 64000 | 2021/12/31 | 328.319 K $ | 579.66 % |
| 2023/09/30 | DICE | DICE Therapeutics Inc. | 0.00% | 0.000 $ | 0 | 2021/12/31 | 0.000 $ | 0.00 % |